Therefore, it appears that FUT3 (in solid malignancies) and FUT7 (in leukemic cells) represent rate-limiting enzymes of sLeA/X synthesis and could be useful targets to block sLeA/X synthesis in cancer cells. This evidence concerns the gene FUT7 and cancer.